Literature DB >> 30281068

Malocclusion Can Give Additional Hints for Diagnosis of Fetal Alcohol Spectrum Disorder.

Moritz Blanck-Lubarsch1, Stefanie Flieger1, Reinhold Feldmann2, Christian Kirschneck3, Cristina Sauerland4, Ariane Hohoff1.   

Abstract

AIMS: Fetal alcohol spectrum disorder (FASD) is a developmental disorder caused by maternal alcohol intake (prevalence: 0.77%). Malocclusion has been described in case reports of patients with FASD, but reliable evidence for associations between FASD and malocclusion is not documented. Malocclusion is defined as tooth irregularity (prevalence: 14.6%) or incorrect relationship between the jaws such as lateral crossbites (prevalence: 3.1%). The purpose of this study was to investigate possible associations between malocclusion and FASD. SHORT
SUMMARY: FASD prevalence is high and diagnosis is very difficult; Malocclusions can give additional hints for FASD diagnosis; Patients with FASD show growth deficits concerning the maxilla; Early and consistent orthodontic supervision and therapy can prevent facial asymmetries in FASD patients.
METHODS: Thirty patients with FASD and 30 patients of a healthy control group were examined. Inclusion criteria were mixed dentition, verified FASD/absence of FASD (control group), exclusion criteria were orthodontic treatment and disorders other than FASD. The extent and type of malocclusion were quantified with the peer assessment rating (PAR) index based on an analysis of orthodontic plaster models. In addition, anthropometric data such as gestational age, body weight and height at birth as well as present body weight, height and head circumference at examination date were assessed.
RESULTS: The PAR index showed a significant increase in malocclusions in FASD patients compared to the group that were not diagnosed with FASD (P = 0.002). FASD patients showed particular differences in the upper transversal dimension with a higher prevalence of crossbites (P = 0.018) and a lower head circumference (P < 0.001). Body weight (P < 0.001) and height (P < 0.001) were significantly lower for FASD patients at time of birth, but not at the present examination date (weight: P = 0.329; height: P = 0.496). When relating weight and height measures to age using percentile curves of physiological growth, clinically relevant discrepancies could be found for FASD patients.
CONCLUSIONS: Our results show that malocclusion can provide additional evidence for FASD diagnosis. When FASD is diagnosed in a child, early referral to an orthodontist is advisable to stimulate maxillary growth and consequently prevent further malocclusions.

Entities:  

Mesh:

Year:  2019        PMID: 30281068     DOI: 10.1093/alcalc/agy071

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  5 in total

1.  The effects of bracketless invisible orthodontics on the PLI, SBI, SPD, and GI and on the satisfaction levels in children with malocclusions.

Authors:  Xiaoteng Shen; Zhuqing Yu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  3D-Analysis of Mouth, Nose and Eye Parameters in Children with Fetal Alcohol Syndrome (FAS).

Authors:  Moritz Blanck-Lubarsch; Dieter Dirksen; Reinhold Feldmann; Cristina Sauerland; Ariane Hohoff
Journal:  Int J Environ Res Public Health       Date:  2019-07-16       Impact factor: 3.390

3.  Children with Fetal Alcohol Syndrome (FAS): 3D-Analysis of Palatal Depth and 3D-Metric Facial Length.

Authors:  Moritz Blanck-Lubarsch; Dieter Dirksen; Reinhold Feldmann; Cristina Sauerland; Ariane Hohoff
Journal:  Int J Environ Res Public Health       Date:  2019-12-21       Impact factor: 3.390

4.  Simplifying Diagnosis of Fetal Alcohol Syndrome Using Machine Learning Methods.

Authors:  Moritz Blanck-Lubarsch; Dieter Dirksen; Reinhold Feldmann; Eike Bormann; Ariane Hohoff
Journal:  Front Pediatr       Date:  2022-01-21       Impact factor: 3.418

5.  Tooth Malformations, DMFT Index, Speech Impairment and Oral Habits in Patients with Fetal Alcohol Syndrome.

Authors:  Moritz Blanck-Lubarsch; Dieter Dirksen; Reinhold Feldmann; Cristina Sauerland; Ariane Hohoff
Journal:  Int J Environ Res Public Health       Date:  2019-11-11       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.